Rite Aid Co. (NYSE:RAD) Receives Consensus Rating of “Hold” from Brokerages
Rite Aid Co. (NYSE:RAD) has been given a consensus rating of “Hold” by the seven brokerages that are covering the stock, MarketBeat reports. Two research analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation and one has assigned a buy recommendation to the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $45.00.
Several research firms have recently issued reports on RAD. Guggenheim reiterated a “sell” rating on shares of Rite Aid in a report on Thursday, April 18th. ValuEngine upgraded shares of Rite Aid from a “hold” rating to a “buy” rating in a report on Thursday, August 1st.
Institutional investors and hedge funds have recently made changes to their positions in the stock. Mercer Global Advisors Inc. ADV bought a new stake in shares of Rite Aid during the first quarter valued at approximately $53,000. Boenning & Scattergood Inc. grew its position in shares of Rite Aid by 124.4% during the 1st quarter. Boenning & Scattergood Inc. now owns 175,500 shares of the company’s stock valued at $111,000 after acquiring an additional 97,300 shares during the period. World Asset Management Inc grew its position in shares of Rite Aid by 120.2% during the 1st quarter. World Asset Management Inc now owns 114,486 shares of the company’s stock valued at $73,000 after acquiring an additional 62,505 shares during the period. MetLife Investment Advisors LLC grew its position in shares of Rite Aid by 30.2% during the 1st quarter. MetLife Investment Advisors LLC now owns 479,222 shares of the company’s stock valued at $304,000 after acquiring an additional 111,199 shares during the period. Finally, Rhumbline Advisers grew its position in shares of Rite Aid by 1.6% during the 1st quarter. Rhumbline Advisers now owns 1,586,561 shares of the company’s stock valued at $1,007,000 after acquiring an additional 25,030 shares during the period.
Rite Aid (NYSE:RAD) last released its earnings results on Wednesday, June 26th. The company reported ($0.14) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.02 by ($0.16). Rite Aid had a negative net margin of 3.40% and a negative return on equity of 1.08%. The business had revenue of $5.37 billion for the quarter, compared to analysts’ expectations of $5.37 billion. During the same quarter in the previous year, the business posted ($0.20) earnings per share. As a group, sell-side analysts forecast that Rite Aid will post 0.16 earnings per share for the current fiscal year.
Rite Aid Company Profile
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. It operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and a range of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products.
Further Reading: Gross Domestic Product (GDP)
Receive News & Ratings for Rite Aid Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rite Aid and related companies with MarketBeat.com's FREE daily email newsletter.